Effectiveness of Oral Tofacitinib in Chronic Pouchitis: A Prospective, Open-Label Pilot Study

By sjmartinez • October 4, 2024

Syal G, Mishkin DS, Banty A, Lee S, Fontelera N, Hampton M, Ziring D, Fleshner PR, Melmed GY. Effectiveness of Oral Tofacitinib in Chronic Pouchitis: A Prospective, Open-Label Pilot Study. Inflamm Bowel Dis. 2024 Oct 3;30(10):1907-1910. doi: 10.1093/ibd/izad191. PMID: 37898112.

Tags: calprotectin, Cedars Sinai DoM, chronic pouchitis, Digestive Diseases, modified pouch disease activity index, Publications, tofacitinib

Intracoronary acetylcholine for vasospasm provocation in women with ischemia and no obstructive coronary artery disease

Tjoe B, Pacheco C, Suppogu N, Samuels B, Rezaeian P, Tamarappoo B, Berman DS, Sharif B, Nelson M, Anderson RD, Petersen J, Pepine CJ, Thomson[...]

Effects of Evolocumab on Coronary Plaque Composition and Microcalcification Activity by Coronary PET and CT Angiography

Han D, Tzolos E, Park R, Gransar H, Hyun M, Friedman JD, Hayes SW, Thomson LEJ, Kwan AC, Budoff M, Shah PK, Kwieciński J, Wetzel[...]

A randomized controlled trial of meditation and health education on carotid intima-media thickness and major adverse cardiovascular events in Black men and women

Norris KC, Salerno J, Bairey Merz CN, Kaushik V, Gelleta S, Castillo A, Nidich S, Gaylord-King C, Schneider RH. A randomized controlled trial of meditation[...]